CTI BioPharma (CTIC) Misses Q1 EPS by 1c

May 3, 2017 4:41 PM

CTI BioPharma (NASDAQ: CTIC) reported Q1 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $8 thousand, versus $36.5 million reported last year.

For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.


Earnings Guidance